Disease	Angiosarcoma
Stage of disease/treatment	Recurrent or metastatic setting
Prior therapy	Chemotherapy-naïve or no more than two previous systemic therapies for recurrent or metastatic setting
Type of study	Interventional
Primary endpoint	Median PFS
Secondary endpoints	Safety profile (the incidence, severity, seriousness, and relatedness to study drug of TEAEs, laboratory changes or LVEF)
	ORR, DCR (ORR + stable disease) at 4 months
	DOR
	Median OS
Investigator’s analysis	Active and should be pursued further